How Turning Down Synthesis Of A Protein Improves Nerve, Muscle Function In Common Neuropathy

English: PET scan of a human brain with Alzhei...

How Turning Down Synthesis Of A Protein Improves Nerve, Muscle Function In Common Neuropathy

A potential new treatment strategy for patients with Charcot-Marie-Tooth diseaseis on the horizon, thanks to research by neuroscientists now at the University at Buffalo’s Hunter James Kelly Research Institute and their colleagues in Italy and England.

The institute is the research arm of the Hunter’s Hope Foundation, established in 1997 by Jim Kelly, Buffalo Bills Hall of Fame quarterback, and his wife, Jill, after their infant son Hunter was diagnosed with Krabbe Leukodystrophy, an inherited fatal disorder of the nervous system. Hunter died in 2005 at the age of eight. The institute conducts research on myelin and its related diseases with the goal of developing new ways of understanding and treating conditions such as Krabbe disease and other leukodystrophies.

Charcot-Marie-Tooth or CMT disease, which affects the peripheral nerves, is among the most common of hereditary neurological disorders; it is a disease of myelin and it results from misfolded proteins in cells that produce myelin.

The new findings were published online earlier this month in The Journal of Experimental Medicine.*

They may have relevance for other diseases that result from misfolded proteins, includingAlzheimer’s disease, Parkinson’s, multiple sclerosis, Type 1 diabetescancer and mad cow disease.

The paper shows that missteps in translational homeostasis, the process of regulating new protein production so that cells maintain a precise balance between lipids and proteins, may be how some genetic mutations in CMT cause neuropathy.

CMT neuropathies are common, hereditary and progressive; in severe cases, patients end up in wheelchairs. These diseases significantly affect quality of life but not longevity, taking a major toll on patients, families and society, the researchers note.

“It’s possible that our finding could lead to the development of an effective treatment not just for CMT neuropathies but also for other diseases related to misfolded proteins,” says Lawrence Wrabetz, MD, director of the institute and professor of neurology and biochemistry in UB’s School of Medicine and Biomedical Sciences and senior author on the paper. Maurizio D’Antonio, of the Division of Genetics and Cell Biology of the San Raffaele Scientific Institute in Milan is first author; Wrabetz did most of this research while he was at San Raffaele, prior to coming to UB.

The research finding centers around the synthesis of misfolded proteins in Schwann cells, which make myelin in nerves. Myelin is the crucial fatty material that wraps the axons of neurons and allows them to signal effectively. Many CMT neuropathies are associated with mutations in a gene known as P0, which glues the wraps of myelin together. Wrabetz has previously shown in experiments with transgenic mice that those mutations cause the myelin to break down, which in turn, causes degeneration of peripheral nerves and wasting of muscles.

When cells recognize that the misfolded proteins are being synthesized, cells respond by severely reducing protein production in an effort to correct the problem, Wrabetz explains. The cells commence protein synthesis again when a protein called Gadd34 gets involved.

“After cells have reacted to, and corrected, misfolding of proteins, the job of Gadd34 is to turn protein synthesis back on,” says Wrabetz. “What we have shown is that once Gadd34 is turned back on, it activates synthesis of proteins at a level that’s too high – that’s what causes more problems in myelination.

“We have provided proof of principle that Gadd34 causes a problem with translational homeostasis and that’s what causes some neuropathies,” says Wrabetz. “We’ve shown that if we just reduce Gadd34, we actually get better myelination. So, leaving protein synthesis turned partially off is better than turning it back on, completely.”

In both cultures and a transgenic mouse model of CMT neuropathies, the researchers improved myelin by reducing Gadd34 with salubrinal, a small molecule research drug. While salubrinal is not appropriate for human use, Wrabetz and colleagues at UB and elsewhere are working to develop derivatives that are appropriate.

“If we can demonstrate that a new version of this molecule is safe and effective, then it could be part of a new therapeutic strategy for CMT and possibly other misfolded protein diseases as well,” says Wrabetz.

And while CMT is the focus of this particular research, the work is helping scientists at the Hunter James Kelly Research Institute enrich their understanding of myelin disorders in general.

“What we learn in one disease, such as CMT, may inform how we think about toxins for others, such as Krabbe’s,” Wrabetz says. “We’d like to build a foundation and answer basic questions about where and when toxicity in diseases begin.”

The misfolded protein diseases are an interesting and challenging group of diseases to study, he continues. “CMT, for example, is caused by mutations in more than 40 different genes,” he says. “When there are so many different genes involved and so many different mechanisms, you have to find a unifying mechanism: this problem of Gadd34 turning protein synthesis on at too high a level could be one unifying mechanism. The hope is that this proof of principle applies to more than just CMT and may lead to improved treatments for Alzheimer’s, Parkinson’s, Type 1 diabetes and the other diseases caused by misfolded proteins.” 


14 Comentarios

    1. Thanks for your comment. The information published on the blog is accessible to everyone for free. Some of this information I share access to that I can enter as a doctor or as a university professor. I intend that this informed the more people posible.Se some files are too technical, but I try to mix them with other information simpler for readers who are not medical devices.
      Interestingly higher discharges occur in articles but tecnicos.Eso means that visitors are increasingly demanding more elaborate and complex information.

      Thanks for writing.

      Jesus Santiago.

  1. Hmm it seems like your website ate my first comment (it was super long) so I guess
    I’ll just sum it up what I submitted and say, I’m thoroughly
    enjoying your blog. I as well am an aspiring blog writer but I’m still new to everything. Do you have any tips for rookie blog writers? I’d certainly appreciate it.

    1. Thank you very much for your opinion.Espero that it remains useful blog for everyone.
      I’m new to blogging, I write every day based on the information that I have and that I can find on the net. Only I do with loving he hopes the information is useful and reach as many people.
      I invite you to visit my new blog,Because I had to change the housing of the Blog, you can follow the updates on the new blog I’ve created: You will have all old news, as well as the all commentary and old files at your disposal in the new blog. Thank you very much and forgive the inconvenience that you may cause. See you in

      Thanks for writing.

  2. Sweet blog! I found it while surfing around on Yahoo News.
    Do you have any suggestions on how to get listed in Yahoo News?
    I’ve been trying for a while but I never seem to get there! Appreciate it

    1. Thanks for your comment

      To be listed in Google has a tool that you can recommend a bone URL a website that is not within their browsers, all you have to do is go to the following link and enter the name of your website with some keywords .

      To get listed in Yahoo Yahoo The good thing is that you search your directory as well as the normal search as Google, now the fact that figures in one does not mean that you will appear in the other, the search in the Yahoo directory is rarely used generally use normal, many people say that if you are in both search engines such as normal directory that will help your position in Google.
      In order to be in Yahoo directory have to do it manually and you have to go to the Yahoo page. The other alternative is to enter URL via the following link “Add URL” does not guarantee you’ll be in the search but nothing proving lose all you have to enter is the URL of your homepage and other content your website is going to find yahoo robots.

      Jesus Santiago.

  3. I am extremely inspired along with your writing talents and also
    with the structure to your weblog. Is this a paid topic or
    did you modify it yourself? Either way keep up the
    nice quality writing, it’s rare to see a nice blog like this one today..

  4. A motivating discussion is worth comment. I do believe that you ought to
    publish more about this subject, it may not be a taboo matter but
    generally people don’t discuss such issues. To the next! Many thanks!!

    1. Thank you very much for your comment, I hope that news of his future are equally interes.Hay are very technical issues, I’m sure that the more you read about it, you will find much easier the understanding of the same. Readers ask increasingly complex information and detailed.
      Thanks for writing.

      See you in my new blog :

      Jesus Santiago.

Responder a Full Article Cancelar respuesta

Por favor, inicia sesión con uno de estos métodos para publicar tu comentario:

Logo de

Estás comentando usando tu cuenta de Cerrar sesión /  Cambiar )

Google photo

Estás comentando usando tu cuenta de Google. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

Conectando a %s